Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 17, 13:38
266.85
1.45 (0.55%)
VOLUME 14,612
LIVE
NSE
Oct 17, 13:38
267.20
1.6 (0.6%)
VOLUME 63,941
Announcements on Advanced Enzyme

17th-Oct-2017 13:35Source: BSE

Advanced Enzyme Technologies- Updates

Intimation regarding dissolution of step-down overseas subsidiary, Enzyfuel Innovation, Inc.

17th-Oct-2017 13:27Source: NSE

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding ''Intimation regarding dissolution of Step-down overseas subsidiary, Enzyfuel Innovation Inc.''.

11th-Oct-2017 17:58Source: BSE

Advanced Enzyme- Compliance Certificate For Half Year Ended September 30, 2017

Compliance Certificate- Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10th-Oct-2017 17:52Source: BSE

Advanced Enzyme- Shareholding for the Period Ended September 30, 2017

Advanced Enzyme Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

6th-Oct-2017 18:24Source: BSE

Advanced Enzyme- Statement Of Investor Complaints For The Quarter Ended September 30, 2017

Statement of Investor Complaints for the Quarter ended September 30, 2017

3rd-Oct-2017 16:08Source: BSE

Advanced Enzyme- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakant Rathi Innovations & Projects Pvt Ltd

27th-Sep-2017 17:03Source: BSE

Advanced Enzyme- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandrakant Rathi Innovations & Projects Pvt Ltd

25th-Sep-2017 19:20Source: BSE

Advanced Enzyme- Investor Presentation

Investor Presentation - September 2017

25th-Sep-2017 19:18Source: BSE

Advanced Enzyme- Analyst / Investor Meet - Intimation

Analyst / Investor Meet - Intimation

20th-Sep-2017 08:18Source: BSE

Advanced Enzyme- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JM Financial Products Ltd

1 2 3 4 5 Next >>
Quick Links for Advanced Enzyme Technologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.